(Total Views: 708)
Posted On: 01/14/2021 9:33:27 PM
Post# of 148899
So I'm not sure what to think here. The closest competitor for CYDY would be OncoImmune that was bought by MRK. They had outstanding results for their interim analysis in September when they had 75% enrollment which was 203 out of 275 patient phase 3 study. I have not seen an EUA submission, or a release that they completed the full study yet?
http://oncoimmune.com/index.php?option=com_k2...Itemid=316
They even have big pharma backing and no completed trial or EUA submission yet? Pretty sure anyone in healthcare is looking for any kind of therapeutic for S/C, and this achieved .005 P value at interim and no trial stoppage? I don't get it. Its quite possible CYDY was off the charts good too, except we actually have finished our trial now without the aid of big pharma or government $$.
MRK could easily have thrown more $$ at the trial sites, we flew one of our VP's around to get the sites enrolling and did the second half enrollment in record time. If this is how Big Pharma is going to treat a possible life saving drug acquisition, no thanks to any buyout.
Also note that the government gave them 356 million for 60-100k doses
https://seekingalpha.com/news/3646907-merck-i...idminus-19
That works out to $3560 per dose...we have 1.2 million vials(500k on hand and 700k at the ready if I remember the CC correctly) at 2 vials per does for 700mg thats a nice little 2 billion dollar cash infusion, if thats the going rate.(I can't validate its 2 vials per dose, thats just what my brain seems to recall, but that info is foggy. )
http://oncoimmune.com/index.php?option=com_k2...Itemid=316
Quote:
“The interim analysis shows safety and outstanding therapeutic efficacy of SACCOVIDTM. The results indicate that patients who received SACCOVIDTM had a 60% better chance to achieve clinical recovery than those who received placebo (P=0.005). The median time to recovery was 6 days for patients treated with SACCOVIDTM compared with 10 days in the placebo group. In addition, the risk of death or respiratory failure is reduced by more than 50%,” said Dr. Pan Zheng, MD, PhD, Chief Medical Officer and co-founder of OncoImmune
They even have big pharma backing and no completed trial or EUA submission yet? Pretty sure anyone in healthcare is looking for any kind of therapeutic for S/C, and this achieved .005 P value at interim and no trial stoppage? I don't get it. Its quite possible CYDY was off the charts good too, except we actually have finished our trial now without the aid of big pharma or government $$.
MRK could easily have thrown more $$ at the trial sites, we flew one of our VP's around to get the sites enrolling and did the second half enrollment in record time. If this is how Big Pharma is going to treat a possible life saving drug acquisition, no thanks to any buyout.
Also note that the government gave them 356 million for 60-100k doses
https://seekingalpha.com/news/3646907-merck-i...idminus-19
That works out to $3560 per dose...we have 1.2 million vials(500k on hand and 700k at the ready if I remember the CC correctly) at 2 vials per does for 700mg thats a nice little 2 billion dollar cash infusion, if thats the going rate.(I can't validate its 2 vials per dose, thats just what my brain seems to recall, but that info is foggy. )
(5)
(0)Scroll down for more posts ▼
